Stryker Past Earnings Performance
Past criteria checks 5/6
Stryker has been growing earnings at an average annual rate of 11.2%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 9.3% per year. Stryker's return on equity is 17.8%, and it has net margins of 16.3%.
Key information
11.2%
Earnings growth rate
10.8%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 9.3% |
| Return on equity | 17.8% |
| Net Margin | 16.3% |
| Next Earnings Update | 28 Jan 2025 |
Recent past performance updates
Recent updates
Here's Why We Think Stryker (NYSE:SYK) Is Well Worth Watching
Jan 17
Stryker: Starting 2025 With A Bolt-On Deal For Inari Medical
Jan 08We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt
Dec 26Stryker Corporation: A Wide-Moat Medical Device Company, But Overvalued
Dec 24Stryker (NYSE:SYK) Is Paying Out A Larger Dividend Than Last Year
Dec 13Investor Optimism Abounds Stryker Corporation (NYSE:SYK) But Growth Is Lacking
Dec 03At US$386, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List?
Nov 21Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC
Oct 16We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease
Oct 10A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)
Sep 29Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Sep 18We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt
Sep 01Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't
Aug 21Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Aug 10Stryker: Wait For A Better Entry Point Post-Q2 Results
Aug 06Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?
Jul 11A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)
Jun 30Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80
Jun 19The Returns At Stryker (NYSE:SYK) Aren't Growing
Jun 16Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Jun 05Stryker: Margin Gains Should Drive Upside
May 31Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?
May 25Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings
May 14Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 02We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease
Apr 29Stryker: A Great Company At An Expensive Price
Apr 05Stryker's (NYSE:SYK) Dividend Will Be $0.80
Mar 26Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Mar 25Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns
Mar 14At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?
Feb 21Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Feb 10Stryker: A Dividend Growth Powerhouse I'd Like To Own
Feb 02Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly
Jan 24Stryker: Mako Shoulder And Spine Launches Are On The Way
Dec 31Why Stryker Is An Awesome Healthcare Compounder
Nov 30Revenue & Expenses Breakdown
How Stryker makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 21,974 | 3,590 | 7,327 | 1,457 |
| 30 Jun 24 | 21,389 | 3,448 | 7,206 | 1,433 |
| 31 Mar 24 | 20,963 | 3,361 | 7,051 | 1,416 |
| 31 Dec 23 | 20,498 | 3,165 | 6,943 | 1,387 |
| 30 Sep 23 | 19,885 | 2,585 | 6,690 | 1,364 |
| 30 Jun 23 | 19,455 | 2,709 | 6,494 | 1,367 |
| 31 Mar 23 | 18,952 | 2,627 | 6,278 | 1,372 |
| 31 Dec 22 | 18,449 | 2,358 | 6,114 | 1,367 |
| 30 Sep 22 | 17,948 | 2,457 | 6,014 | 1,372 |
| 30 Jun 22 | 17,629 | 2,079 | 5,925 | 1,322 |
| 31 Mar 22 | 17,430 | 2,015 | 5,929 | 1,281 |
| 31 Dec 21 | 17,108 | 1,994 | 5,752 | 1,235 |
| 30 Sep 21 | 16,669 | 1,900 | 5,525 | 1,159 |
| 30 Jun 21 | 16,246 | 2,083 | 5,297 | 1,095 |
| 31 Mar 21 | 14,716 | 1,408 | 4,900 | 1,018 |
| 31 Dec 20 | 14,351 | 1,599 | 4,759 | 984 |
| 30 Sep 20 | 14,220 | 1,756 | 4,766 | 983 |
| 30 Jun 20 | 14,070 | 1,601 | 4,824 | 987 |
| 31 Mar 20 | 14,956 | 2,164 | 4,995 | 1,000 |
| 31 Dec 19 | 14,884 | 2,083 | 4,968 | 971 |
| 30 Sep 19 | 14,549 | 3,426 | 4,970 | 938 |
| 30 Jun 19 | 14,204 | 3,550 | 4,914 | 913 |
| 31 Mar 19 | 13,876 | 3,522 | 4,864 | 883 |
| 31 Dec 18 | 13,601 | 3,553 | 4,808 | 862 |
| 30 Sep 18 | 13,276 | 1,236 | 4,687 | 846 |
| 30 Jun 18 | 13,040 | 1,080 | 4,556 | 823 |
| 31 Mar 18 | 12,730 | 1,019 | 4,484 | 799 |
| 31 Dec 17 | 12,444 | 1,020 | 4,380 | 787 |
| 30 Sep 17 | 12,130 | 1,779 | 4,239 | 771 |
| 30 Jun 17 | 11,957 | 1,700 | 4,167 | 757 |
| 31 Mar 17 | 11,785 | 1,689 | 4,076 | 748 |
| 31 Dec 16 | 11,325 | 1,647 | 3,941 | 715 |
| 30 Sep 16 | 10,883 | 1,659 | 3,828 | 690 |
| 30 Jun 16 | 10,470 | 1,605 | 3,703 | 661 |
| 31 Mar 16 | 10,062 | 1,617 | 3,591 | 632 |
| 31 Dec 15 | 9,946 | 1,439 | 3,511 | 625 |
| 30 Sep 15 | 9,849 | 1,177 | 3,445 | 614 |
| 30 Jun 15 | 9,818 | 933 | 3,417 | 612 |
| 31 Mar 15 | 9,749 | 669 | 3,381 | 616 |
| 31 Dec 14 | 9,675 | 515 | 3,356 | 614 |
| 30 Sep 14 | 9,525 | 641 | 2,851 | 600 |
| 30 Jun 14 | 9,287 | 687 | 3,147 | 583 |
| 31 Mar 14 | 9,136 | 772 | 3,305 | 557 |
Quality Earnings: SYK has high quality earnings.
Growing Profit Margin: SYK's current net profit margins (16.3%) are higher than last year (13%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SYK's earnings have grown by 11.2% per year over the past 5 years.
Accelerating Growth: SYK's earnings growth over the past year (38.9%) exceeds its 5-year average (11.2% per year).
Earnings vs Industry: SYK earnings growth over the past year (38.9%) exceeded the Medical Equipment industry 15%.
Return on Equity
High ROE: SYK's Return on Equity (17.8%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/20 03:41 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Stryker Corporation is covered by 71 analysts. 27 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| David Toung | Argus Research Company |
| Richard Purkiss | Atlantic Equities LLP |
| Jeffrey Johnson | Baird |